Paradigm Health

Paradigm Health is building a platform to address systemic inefficiencies in clinical research. The company integrates directly with healthcare provider organizations to combine technology and services, with the aim of enhancing trial efficiency and reducing barriers to patient participation. Its work is situated at the intersection of clinical research, healthcare, and life sciences.

The company's core offering is the Intelligent Research Platform, which connects patients, providers, and trial sponsors through a unified infrastructure. The platform is designed to accelerate the delivery of therapies by improving enrollment and reducing administrative burden. Partners such as Highlands Oncology have reported a 45% increase in clinical trial enrollment while decreasing demands on their research departments.

Paradigm Health's mission-driven approach is informed by structural challenges in drug development: roughly half of all drugs fail to meet enrollment targets, and the average cost to develop a new drug is approximately $2 billion. The company positions its technology as a means to make the clinical trial process more equitable and accessible to a broader patient population.